Literature DB >> 1994738

Psychosocial factors in maternal phenylketonuria: prevention of unplanned pregnancies.

S E Waisbren1, S Shiloh, P St James, H L Levy.   

Abstract

BACKGROUND: Women with phenylketonuria (PKU) not treated prior to conception can have a pregnancy that results in serious fetal damage. In this report, factors associated with preventing unplanned (and hence late treated) pregnancies are described.
METHODS: Subjects included 60 phenylketonuric women and two comparison groups composed of female acquaintances and diabetic women. All were interviewed and administered tests of intelligence, general well-being, knowledge, and personality.
RESULTS: Thirty-five percent of the sexually active women with PKU used contraception only sporadically. The variables that best predicted reported frequency of birth control use were the extent to which women felt social support to use contraception (r = .64) along with positive attitudes about birth control (r = .66) and knowledge of family planning (r = .43). For the comparison groups, a different pattern of variables predicted contraceptive use, with locus of control figuring most prominently for the diabetics (r = .39) and social support for birth control being most important for the acquaintances (r = .46).
CONCLUSIONS: As more girls with PKU enter childbearing ages, there will be an increased need for specific programs that address psychosocial factors in maternal PKU.

Entities:  

Mesh:

Year:  1991        PMID: 1994738      PMCID: PMC1405020          DOI: 10.2105/ajph.81.3.299

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  18 in total

1.  Internal-external locus of control and the practice of birth control.

Authors:  A P MacDonald
Journal:  Psychol Rep       Date:  1970-08

2.  Predicting male and female contraceptive behavior: a discriminant analysis of groups high, moderate, and low in contraceptive effectiveness.

Authors:  B D Geis; M Gerrard
Journal:  J Pers Soc Psychol       Date:  1984-03

3.  Phenylketonuria: epitome of human biochemical genetics (second of two parts).

Authors:  C R Scriver; C L Clow
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

4.  A preliminary report of the collaborative study of maternal phenylketonuria in the United States and Canada.

Authors:  R Koch; W Hanley; H Levy; R Matalon; B Rouse; F Dela Cruz; C Azen; E Gross Friedman
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

5.  Diet policies of PKU clinics in the United States.

Authors:  V E Schuett; E S Brown
Journal:  Am J Public Health       Date:  1984-05       Impact factor: 9.308

6.  Maternal phenylketonuria--results of dietary therapy.

Authors:  R R Lenke; H L Levy
Journal:  Am J Obstet Gynecol       Date:  1982-03-01       Impact factor: 8.661

7.  Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus.

Authors:  H L Levy; S E Waisbren
Journal:  N Engl J Med       Date:  1983-11-24       Impact factor: 91.245

8.  Projections of a rebound in frequency of mental retardation from phenylketonuria.

Authors:  H N Kirkman
Journal:  Appl Res Ment Retard       Date:  1982

9.  Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

Authors:  R R Lenke; H L Levy
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

10.  Prevention of mental retardation in offspring of hyperphenylalaninemic mothers.

Authors:  L Cartier; C L Clow; A Lippman-Hand; J Morissette; C R Scriver
Journal:  Am J Public Health       Date:  1982-12       Impact factor: 9.308

View more
  6 in total

1.  Social factors and the meaning of food in adherence to medical diets: results of a maternal phenylketonuria summer camp.

Authors:  S E Waisbren; H Rokni; I Bailey; F Rohr; T Brown; J Warner-Rogers
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

2.  Psychosocial factors in maternal phenylketonuria: women's adherence to medical recommendations.

Authors:  S E Waisbren; B D Hamilton; P J St James; S Shiloh; H L Levy
Journal:  Am J Public Health       Date:  1995-12       Impact factor: 9.308

3.  Agoraphobia in phenylketonuria.

Authors:  S E Waisbren; H L Levy
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 4.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

5.  Promoting psychological well-being in women with phenylketonuria: Pregnancy-related stresses, coping strategies and supports.

Authors:  Rachel M Roberts; Tamara Muller; Annabel Sweeney; Drago Bratkovic; Anne Gannoni
Journal:  Mol Genet Metab Rep       Date:  2014-04-17

6.  Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy.

Authors:  Carmen Rohde; Alena Gerlinde Thiele; Christoph Baerwald; Rudolf Georg Ascherl; Dinah Lier; Ulrike Och; Christina Heller; Alexandra Jung; Kathrin Schönherr; Monika Joerg-Streller; Simone Luttat; Sabine Matzgen; Tina Winkler; Stefanie Rosenbaum-Fabian; Oxana Joos; Skadi Beblo
Journal:  Orphanet J Rare Dis       Date:  2021-11-18       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.